ARTICLE | Clinical News
Somatoprim: Phase IIa data
April 8, 2013 7:00 AM UTC
Top-line data from an open-label, Ukrainian Phase IIa trial in about 20 treatment-naïve patients with acromegaly showed that single ascending-doses of subcutaneous Somatoprim dose-dependently reduced ...